---
figid: PMC9433080__cm9-135-1272-g001
figtitle: Treating non-small cell lung cancer by targeting the PI3K signaling pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC9433080
filename: cm9-135-1272-g001.jpg
figlink: /pmc/articles/PMC9433080/figure/F1/
number: F1
caption: 'PI3K pathway and its role in the occurrence and development of NSCLC. AKT:
  Protein kinase B; BAD: Bcl-xL/Bcl-2 associated death promoter; CASP: Caspase; CHEK1:
  Checkpoint kinase 1; FOXO: Forkhead box O; GPCR: G protein-coupled receptor; GSK3:
  Glycogen synthesis kinase 3; HIF-1: Hypoxia-inducible factor 1; IκB: Inhibitor of
  nuclear factor kappa-B; IKK: Inhibitor of nuclear factor kappa-B kinase; MDM2: Murine
  double minute 2; mTORC: Mammalian target of rapamycin complex; NF-κB: Nuclear factor
  kappa-light chain enhancer of activated B cells; NO: Nitric oxide; NSCLC: Non-small
  cell lung cancer; P53: Protein 53; PDK1: Pyruvate dehydrogenase kinase 1; PI3K:
  Phosphosphatidylinositol-3-kinase; PIP2: Phosphatidylinositol 4,5-bisphosphate;
  PIP3: Phosphatidylinositol-3,4,5-triphosphate; PTEN: Phosphatase and tensin homolog;
  RHO: Ras homolog; RTKs: Receptor tyrosine kinases; TSC: Tuberous sclerosis complex;
  VEGF: Vascular endothelial growth factor.'
papertitle: Treating non-small cell lung cancer by targeting the PI3K signaling pathway.
reftext: Lin Jiang, et al. Chin Med J (Engl). 2022 Jun 5;135(11):1272-1284.
year: '2022'
doi: 10.1097/CM9.0000000000002195
journal_title: Chinese Medical Journal
journal_nlm_ta: Chin Med J (Engl)
publisher_name: Lippincott Williams & Wilkins
keywords: Phosphosphatidylinositol-3-kinase signaling pathway | Protein kinase B |
  Mammalian target of rapamycin | Non-small cell lung cancer
automl_pathway: 0.9525443
figid_alias: PMC9433080__F1
figtype: Figure
redirect_from: /figures/PMC9433080__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9433080__cm9-135-1272-g001.html
  '@type': Dataset
  description: 'PI3K pathway and its role in the occurrence and development of NSCLC.
    AKT: Protein kinase B; BAD: Bcl-xL/Bcl-2 associated death promoter; CASP: Caspase;
    CHEK1: Checkpoint kinase 1; FOXO: Forkhead box O; GPCR: G protein-coupled receptor;
    GSK3: Glycogen synthesis kinase 3; HIF-1: Hypoxia-inducible factor 1; IκB: Inhibitor
    of nuclear factor kappa-B; IKK: Inhibitor of nuclear factor kappa-B kinase; MDM2:
    Murine double minute 2; mTORC: Mammalian target of rapamycin complex; NF-κB: Nuclear
    factor kappa-light chain enhancer of activated B cells; NO: Nitric oxide; NSCLC:
    Non-small cell lung cancer; P53: Protein 53; PDK1: Pyruvate dehydrogenase kinase
    1; PI3K: Phosphosphatidylinositol-3-kinase; PIP2: Phosphatidylinositol 4,5-bisphosphate;
    PIP3: Phosphatidylinositol-3,4,5-triphosphate; PTEN: Phosphatase and tensin homolog;
    RHO: Ras homolog; RTKs: Receptor tyrosine kinases; TSC: Tuberous sclerosis complex;
    VEGF: Vascular endothelial growth factor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TP53
  - TP63
  - TP73
  - PTEN
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - BAD
  - CASP9
  - MDM2
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - AKT1
  - AKT2
  - AKT3
  - PDK1
  - PDPK1
  - TSC1
  - CCL26
  - FOXO1
  - FOXO3
  - GSK3A
  - GSK3B
  - SETD2
  - TSC2
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - NFKB1
  - RHEB
  - RHEBP1
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - MTOR
  - RPTOR
  - RAD51
  - CHEK1
---
